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Death from pan-resistant superbug
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Acinetobacter baumannii has emerged as a pan-resistant superbug causing fatal infections in vulnerable patients. This 
report is the case of an immunosuppressed transplant patient with a fatal pneumonia due to pan-resistant Acinetobacter 
baumannii. Alternative therapy for resistant Acinetobacter infection is currently the subject of intense interest and 
research. This report illustrates the features of this type of emerging infectious disease and reviews some of the novel 
approaches to treatment.  
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CASE REPORT
This 48-year-old white male presented with 
progressive dyspnea. He had first developed dyspnea 
on exertion in his third decade of life, between 
20 and 29 years of age. He had a 4 pack-year history of 
smoking, which he discontinued when he began having 
dyspnea on exertion. He carried a diagnosis of asthma 
treated with various inhalers and corticosteroids with 
inconsistent results. Progressive dyspnea eventually 
prompted a referral to a pulmonologist, who diagnosed 
alpha-1-antitrypsin deficiency and began replacement 
therapy with weekly infusions of alpha-1-proteinase 
inhibitor, starting 4 years prior. The patient experienced 
a decreased frequency of exacerbations of his 
pulmonary disease initially following replacement 
therapy. He was also put on daily corticosteroid 
therapy and had 3 or 4 hospitalizations per year for 
exacerbations, which were treated with high dose 
corticosteroid therapy and antibiotics. The patient 
also had a history of hypertension, osteoporosis, a 
pulmonary nodule unchanged over several years, and 
a pancreato-duodenal artery aneurysm managed with 
embolization. He had no history of liver disease. He had 
a sister with alpha-1-antitrypsin deficiency.
The patient presented for lung transplant 
evaluation when computed tomography (CT) scan 
of the chest showed diffuse panlobular emphysema 
involving all lobes of both lungs. Pulmonary function 
tests revealed a first-second forced expiratory volume 
(FEV1) 16% of predicted, forced vital capacity (FVC) 
40% of predicted, vital capacity (VC) 43% of predicted, 
total lung capacity (TLC) 144% of predicted and 
diffusing capacity of the lungs for carbon monoxide 
(DLCO) 20% of predicted. Arterial blood showed 
pH 7.44, PCO2 44 mm Hg and PO2 63 mm Hg. 
Transthoracic echocardiogram showed normal 
left ventricular size and function (ejection fraction 
55-60%) and a mildly dilated right ventricle with mildly 
decreased function. Cardiac catheterization revealed 
lesions of the left anterior descending coronary artery 
(mid 80% and 90% sequential).
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Four months later, the patient underwent double 
lung transplantation and coronary artery bypass 
grafting. The coronary artery bypass grafting was 
initially performed using the left internal mammary 
artery, but hypokinesis of the distal anterior left 
ventricular wall prompted revision of the bypass grafting 
using a saphenous vein. Pathologic examination of the 
patient’s native lungs showed bullous emphysema, 
bronchiectasis, focal dust macules, macrophages with 
dust particles, airspace “smoker’s macrophages”, 
and reactive peribronchial lymph nodes, some with 
anthracosilicotic nodules.
In the immediate postoperative period, the 
patient had hypotension requiring infusions of 
two vasopressors, epinephrine and phenylephrine. 
His postoperative medications included tacrolimus, 
mycophenolate, alemtuzumab and methylprednisolone, 
along with aztreonam, voriconazole, valganciclovir and 
metronidazole.
Bleeding complicated the patient’s postoperative 
course, with excessive chest tube drainage. His platelet 
count was 191,000/mm3 (reference range [RR]: 
156,000-369,000/mm3), international normalized ratio 
(INR) 1.2 (RR: 0.8-1.2) and partial thromboplastin time 
(PTT) 37.8 seconds (RR: 25-33 seconds). He continued to 
have excessive chest tube drainage despite transfusion 
of fresh frozen plasma and platelets. On postoperative 
day 1 (PO1), the patient’s chest was explored. He had 
small areas of oozing including one area of mild oozing 
from the posterior of the left atrial right pulmonary 
venous suture line, which was closed with sutures, 
while other areas of oozing were treated with cautery. 
Blood was evacuated from the pleural cavities.
The patient’s respiratory function was adequate 
to permit extubation on PO3. Sterility cultures 
from the donor right bronchus were positive for 
methicillin-sensitive Staphylococcus aureus and the 
patient was treated with cefazolin. Between PO1 
and PO8, the patient had improving lung function. 
Subcutaneous emphysema of the left chest and 
hyponatremia were the main problems during this 
period.
On PO10, computed tomography of the chest 
showed moderate bilateral anterior pneumothoraces 
and left pleurocutaneous communication. Between 
PO9 and PO14, the patient was relatively stable, 
although he had persistently low blood pressure 
treated with fludrocortisone. On PO14, the patient’s 
blood pressure was 87/47 mm Hg. On the day after, 
the patient had pain his ribs and legs. His temperature 
was 36.8o C, heart rate 104/minute, blood pressure 
75/46 mm Hg, respirations 18/minute, and saturation 
98% on supplemental oxygen at 2 L/minute. He had 
slightly decreased chest wall subcutaneous emphysema, 
along with a persistent air leak, scattered rhonchi in 
both bases, non-tender abdomen and moderate 
edema of the distal lower extremities. His hemoglobin 
(Hgb) was 7.1 g/dL (RR: 12.9-16.9 g/dL), white blood 
cell count 9,000/mm3 (RR: 3,800-10,600/mm3), 
platelet count 330,000/mm3, creatinine 2.2 mg/dL 
(RR: 0.8-1.5 mg/dL) and tacrolimus level 8.9 ng/mL. 
His evening dose of tacrolimus was held.
On PO16, the patient’s cl inical condit ion 
deteriorated. He had worsening hypotension with a 
central venous pressure of 11 mm Hg and was started 
on an infusion of dopamine. He had decreasing urine 
output. He had findings of possible early cellulitis 
in his legs and was restarted on cefazolin, while 
voriconazole and valganciclovir were discontinued. 
His white blood cell count was 15,900/mm3 (50% 
neutrophils, 48% bands, 2% monocytes), platelet 
count 347,000/mm3, urea nitrogen 214 mg/dL 
(RR: 10-42 mg/dL), creatinine 2.3 mg/dL, bilirubin 
2.9 mg/dL (RR: 0.3-1.5 mg/dL), alkaline phosphatase 
939 U/L (RR: 40-125 U/L), alanine aminotransferase 
(ALT) 64 U/L (RR: <40 U/L), gamma-glutamyl-transferase 
(GGT) 709 U/L (RR: <30 U/L), albumin 2.6 g/dL 
(RR: 3.5-5 g/dL) and tacrolimus level 12.8 ng/mL. 
Tacrolimus was held. Computed tomography showed 
right lower lobe pneumonia, bilateral pneumothoraces, 
bilateral chest tubes in good position and subcutaneous 
emphysema. He was transfused 2 units of red blood 
cells with an increase in his Hgb to 11.3 g/dL
On PO17, in the morning, the patient’s Hgb was 
10.1 g/dL, white blood cell count 8,500/mm3 (53% 
neutrophils, 35% bands, 3% lymphocytes), platelets 
165,000/mm3, urea nitrogen 231,4 mg/dL, creatinine 
1.9 mg/dL, bilirubin 2.5 mg/dL, alkaline phosphatase 
614 U/L, ALT 42 U/L, GGT 481 U/L, albumin 1.6 g/dL 
and tacrolimus level 10.1 ng/mL. In the afternoon, the 
patient’s clinical condition deteriorated; he required 
an increasing fraction of inspired oxygen (FiO2), up to 
90%, to maintain an adequate PO2. At 14:19 chest 
x-ray showed consolidation of right mid and lower lung 
zones. He was intubated and bronchoscopy showed an 
area in the membranous portion of the right bronchial 
anastomosis where 2 of the running sutures appeared 
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to be pulled off the epithelium, through which a clip 
could be seen. There was no air bubbling through, 
but there was evidence of disruption of the superficial 
layers. Gram stain of Bronchoalveolar lavage showed 
many white blood cells and many Gram-negative rods 
and many Gram-positive cocci in pairs. The patient was 
given empirical antibiotic therapy with meropenem 
and a dose of vancomycin. He required increasing 
vasopressor support with epinephrine and vasopressin. 
He had severe acidosis pH 7.16, PCO2 59 mm 
Hg and PO2 87 mm Hg at 17:20. He was given 
sodium bicarbonate. His hypoxemia did not improve 
despite an FiO2 of 100% and increasing positive 
end-expiratory pressure. At 22:57, chest radiograph 
showed worsening bilateral airspace consolidation.
On PO18, at 01:00, arterial blood showed 
pH 7.19, PCO2 83 mm Hg, PO2 61 mm Hg, bicarbonate 
30 mEq/L (RR: 22-26 mEq/L), lactate 14.2 mEq/L 
(RR: 0.5-1.6 mEq/L), Hgb 10.4 g/dL and potassium 
4.3 mEq/L (RR: 3.5-5 mEq/L). The patient had a very 
poor prognosis. A decision was reached with his 
family not to further escalate interventions, and not 
to perform cardiopulmonary resuscitation. The patient 
died an hour later.
AUTOPSY FINDINGS
Postmortem examination revealed acute bacterial 
pneumonia, severe in the right middle lobe and 
moderate in the right upper lobe. The right lower 
lobe showed pneumonia that was moderate and in 
an early subacute phase. There was severe subacute 
pneumonia in the left lower lobe (Figure 1) and mild 
fibrinous pleuritis over both lungs.
Autopsy revealed severe acute bronchitis with 
invading bacteria and a gap exposing 2 sutures at 
the right bronchial anastomosis. Gram stain of lung 
showed myriads of Gram-negative bacilli (Figure 2).
Autopsy also showed extensive hepatocyte 
hydropic degeneration (nonspecific edema) with 
alpha-1-antitrypsin globules (specific confirmation 
of the diagnosis of alpha-1-antitrypsin deficiency). 
The heart had findings of subendocardial ischemia 
and infarction of the upper septum and (focally) right 
ventricle and (at pulmonary venous anastomosis) left 
atrium, but the saphenous vein bypass graft to the 
left anterior descending coronary artery was patent, 
without lesions. The adrenal glands showed cortical 
atrophy. Postmortem lung culture was positive 
for heavy growth of Acinetobacter baumannii. 
Postmortem blood and spleen cultures were also 
positive for Acinetobacter baumannii. Following 
the patient’s death, bronchoalveolar lavage culture 
from PO17 were reported positive for >100,000/mL 
Acinetobacter baumannii resistant to all antibiotics 
tested. Blood cultures from the same day were also 
reported positive for Acinetobacter baumannii resistant 
to all antibiotics tested.
Figure 1. Photomicrograph of the lung. The alveoli are 
filled with inflammatory cells mixed with some fibrin 
and a few red blood cells. Most of the inflammatory 
cells are macrophages (characteristic of subacute phase 
pneumonia), replacing neutrophils (characteristic of 
acute phase pneumonia) (H&E,200X).
Figure 2. Photomicrograph of the lung. There are large 
numbers of small Gram-negative coccobacilli, many of 
them intracellular (Brown and Brenn, 400X).
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DISCUSSION
Acinetobacter baumannii has emerged as a 
life-threatening pathogen in vulnerable patients 
with, for instance, immunosuppression, cancer or 
neonatal hospitalization.1-3 The pathogenicity of 
Acinetobacter is not due to virulence, but rather its 
resistance to antibiotics and ability to persist on the 
surfaces of beds, curtains, walls, medical devices, 
tap water sinks, telephones, door handles, hand 
sanitizers and computer keyboards.4 Acinetobacter is 
a special scourge as a cause of pneumonia in patients 
on mechanical ventilation in hospital intensive care 
units.5 It is noteworthy that the patient of this case 
report was not only on mechanical ventilation in an 
intensive care unit, but was also immunosuppressed 
for transplantation.
The patient of this case report had a bacteremic 
infection and the infection was fatal. Fatality 
in bacteremic infections with carbapenem and 
colistin resistant Gram-negative bacilli has been 
linked to the antibiotic resistance. In one study, 
30-day all-cause mortality was 22% in patients 
with carbapenem sensitive bacteremia and 62% in 
patients with carbapenem resistant bacteraemia.6 
This raises the specter of lethal untreatable infections, 
which had passed out of most living memory since 
the pre-antibiotic era. Deaths from untreatable 
infections like the one in this case report have led 
some to suggest that we are seeing the start of a 
post-antibiotic era.7
The emergence of infections by superbug 
pan-resistant Acinetobacter has spurred intense 
research into alternative therapies. One of the leading 
alternative therapies is with bacteriophages, viruses of 
bacteria, which had passed out of favor in the antibiotic 
era of the past hundred years.8 In one well-publicized 
case of a 68-year-old diabetic patient with necrotizing 
pancreatitis complicated by a multi-drug resistant 
Acinetobacter baumannii infection, he deteriorated over 
4 months despite percutaneous drainage of a pancreatic 
pseudocyst. Two laboratories identified nine different 
bacteriophages with lytic activity for an Acinetobacter 
isolate from this patient, and administration of these 
bacteriophages intravenously and percutaneously into 
the abscess cavities was associated with reversal of 
the patient’s downward clinical trajectory, clearance 
of the Acinetobacter infection, and a return to 
health.9 One of the major factors contributing to 
antibiotic resistance in Acinetobacter baumannii 
infections is biofilm development. Quorum sensing 
facilitates biofilm formation and therefore quorum 
quenching substances have emerged as a possible 
alternative therapy.10 Another strategy is to combine 
antibiotics with new beta-lactamase inhibitors, for 
which the search is on.11 Yet another strategy is 
one that utilizes knowledge from the era before 
bacteriophage therapy. A shortage of conventional 
medicine during the American Civil War (1861-1865) 
spurred Confederate physicians to use preparations of 
native plants as medicines. In 1863, botanist Francis 
Porcher compiled a book of medicinal plants native to 
the southern United States, including plants used in 
Native American traditional medicine. Testing these 
plant substances has shown some efficacy in inhibiting 
the growth, biofilm formation, and quorum sensing 
by multidrug-resistant bacteria.12
In the meantime, while these alternative therapies 
are in development, the most important aspect of these 
infections is prevention.5,13 The unit in which the patient 
of this case report was hospitalized had a significant 
incidence of extensively resistant and pan-resistant 
Acinetobacter baumannii infections.14 In this unit, 
the emergence of colistin-resistant Acinetobacter 
baumannii was almost exclusively in patients who 
had received colistin for carbapenem-resistant 
Acinetobacter baumannii infection.14 This makes 
antibiotic stewardship aimed at limiting the use of 
antibiotics causing the emergence of resistance a 
crucial element in prevention. In outbreaks, enhanced 
audit to identify common sources, particularly 
contaminated equipment or fomites, and feedback of 
environmental cleaning can be helpful.13 Healthcare 
worker hand hygiene, contact precautions and 
cohorting can aid in stemming outbreaks. Routine 
chlorhexidine bathing has been part of the infection 
control bundle curtailing some outbreaks.13 Infections 
with pan-resistant pathogens are often preceded by 
colonization, so another important aspect of these 
infections is prevention of colonization.15 The case 
reported here illustrates the urgency of the problem 
of pan-resistant superbugs.
Informed consent for the autopsy was given by 
the next of kin and manuscripts of case reports are not 
reviewed by the Institutional Review Board.
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